An innovative startup company from Cape Town, South Africa has joined Maryland’s medtech community.
Impulse Biomed is a multi-medical device development company, focusing on providing affordable and reliable medical solutions. The company’s products include an accessible device for asthma inhalers called Easy Squeezy, and the ZiBiPen, a patented reloadable autoinjector that can be used for anaphylaxis.
The company will be located at Baltimore’s LaunchPort as part of the state’s Global Gateway Soft Landing Program, which gives international companies the opportunity to test out the U.S. market while mitigating some of the risk.
“We believe that Maryland is the ideal launchpad for the ZiBiPen in particular,” said Impulse Biomed Co-Founder Gokul Nair. “The ecosystem offers a direct line to regulatory expertise, manufacturing infrastructure, and commercial partners essential for market disruption and, of course, impact.”
Approximately 80 companies from around the world have joined the state’s soft landing program over the last three years.
